Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
ENDI shares declined from $16.75 at the end of 2025 to $15.00 at the end of the first quarter. In March, the...
— Steven Kiel
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Endi Corp
More institutional theses from Arquitos Capital Management
Liquidia was the fund's largest contributor in 2025. The fund holds...
United Therapeutics is discussed strictly as Liquidia's key competitor and the opposing party in critical patent litigation. Its market multiple...
Finch is executing a strategic Chapter 11 filing to shed lease liabilities and execute a full sale of its assets, including valuable patents and major ongoing litigation claims. The manager believes...